BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24147835)

  • 21. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
    Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
    Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells.
    Carrión J; Folgueira C; Alonso C
    Vaccine; 2008 May; 26(20):2537-44. PubMed ID: 18400342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs.
    Mettler M; Grimm F; Capelli G; Camp H; Deplazes P
    J Clin Microbiol; 2005 Nov; 43(11):5515-9. PubMed ID: 16272479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCL10 treatment promotes reduction of IL-10
    Eufrásio de Figueiredo WM; Heredia FF; Santos AS; da Rocha Braga R; Marciano Fonseca FR; Lúcia de Castro Rodrigues N; Abreu TM; Maria de Lima Pompeu M; Barbosa HS; Teixeira MJ
    Exp Parasitol; 2019 Dec; 207():107789. PubMed ID: 31669169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model.
    Requena JM; Soto M; Doria MD; Alonso C
    Vet Immunol Immunopathol; 2000 Oct; 76(3-4):269-81. PubMed ID: 11044559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
    Rafati S; Zahedifard F; Azari MK; Taslimi Y; Taheri T
    Exp Parasitol; 2008 Mar; 118(3):393-401. PubMed ID: 18093586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection.
    Parody N; Soto M; Requena JM; Alonso C
    Parasite Immunol; 2004; 26(6-7):283-93. PubMed ID: 15541032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Label-free electrochemical impedance immunosensor based on modified screen-printed gold electrodes for the diagnosis of canine visceral leishmaniasis.
    Cordeiro TAR; Gonçalves MVC; Franco DL; Reis AB; Martins HR; Ferreira LF
    Talanta; 2019 Apr; 195():327-332. PubMed ID: 30625550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
    Agallou M; Margaroni M; Karagouni E
    Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection.
    Honoré S; Garin YJ; Sulahian A; Gangneux JP; Derouin F
    FEMS Immunol Med Microbiol; 1998 Jul; 21(3):231-9. PubMed ID: 9718213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research progress on the diagnosis technology of canine visceral leishmaniasis].
    Ding D; Wang JY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Oct; 30(5):406-10. PubMed ID: 23484286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection.
    Silva AM; Tavares J; Silvestre R; Ouaissi A; Coombs GH; Cordeiro-da-Silva A
    Parasite Immunol; 2012 Jun; 34(6):345-50. PubMed ID: 22416787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to Leishmania infantum in healthy horses in Spain.
    Fernández-Bellon H; Solano-Gallego L; Bardagí M; Alberola J; Ramis A; Ferrer L
    Vet Parasitol; 2006 Jan; 135(2):181-5. PubMed ID: 16213661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.
    Moreira Nd; Vitoriano-Souza J; Roatt BM; Vieira PM; Ker HG; de Oliveira Cardoso JM; Giunchetti RC; Carneiro CM; de Lana M; Reis AB
    PLoS One; 2012; 7(10):e47907. PubMed ID: 23112869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine-based antigen detection assay for diagnosis of visceral leishmaniasis using monoclonal antibodies specific for six protein biomarkers of Leishmania infantum / Leishmania donovani.
    Abeijon C; Alves F; Monnerat S; Mbui J; Viana AG; Almeida RM; Bueno LL; Fujiwara RT; Campos-Neto A
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008246. PubMed ID: 32324742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.
    García-García JA; Martín-Sánchez J; Gállego M; Rivero-Román A; Camacho A; Riera C; Morillas-Márquez F; Vergara S; Macías J; Pineda JA
    J Clin Microbiol; 2006 Dec; 44(12):4455-8. PubMed ID: 17050814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.